Shenghui Xue
Overview
Explore the profile of Shenghui Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li D, Kirberger M, Qiao J, Gui Z, Xue S, Pu F, et al.
Invest Radiol
. 2024 Jan;
59(2):170-186.
PMID: 38180819
Cancer and other acute and chronic diseases are results of perturbations of common molecular determinants in key biological and signaling processes. Imaging is critical for characterizing dynamic changes in tumors...
2.
Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent
Ibhagui O, Li D, Han H, Peng G, Meister M, Gui Z, et al.
Chem Biomed Imaging
. 2023 Jun;
1(3):268-285.
PMID: 37388961
Chronic lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), are major leading causes of death worldwide and are generally associated with poor prognoses. The...
3.
Tan S, Yang H, Xue S, Qiao J, Salarian M, Hekmatyar K, et al.
Sci Adv
. 2020 Feb;
6(6):eaav7504.
PMID: 32083172
Liver metastases often progress from primary cancers including uveal melanoma (UM), breast, and colon cancer. Molecular biomarker imaging is a new non-invasive approach for detecting early stage tumors. Here, we...
4.
Salarian M, Turaga R, Xue S, Nezafati M, Hekmatyar K, Qiao J, et al.
Nat Commun
. 2019 Oct;
10(1):4777.
PMID: 31664017
Early diagnosis and noninvasive detection of liver fibrosis and its heterogeneity remain as major unmet medical needs for stopping further disease progression toward severe clinical consequences. Here we report a...
5.
Salarian M, Yang H, Turaga R, Tan S, Qiao J, Xue S, et al.
Biomaterials
. 2019 Sep;
224:119478.
PMID: 31542517
The Liver is the most common organ for metastasis for various cancers, including uveal melanoma, the most common primary intraocular tumor. Uveal melanoma metastasizes to the liver in ~90% of...
6.
Salarian M, Xue S, Ibhagui O, Yang J
Methods Mol Biol
. 2019 Feb;
1929:111-125.
PMID: 30710270
Early diagnosis, noninvasive detection, and staging of various diseases, remain one of the major clinical barriers to effective medical treatment and prevention of disease progression toward major clinical consequences. Molecular...
7.
8.
Pu F, Salarian M, Xue S, Qiao J, Feng J, Tan S, et al.
Nanoscale
. 2016 Mar;
8(25):12668-82.
PMID: 26961235
Prostate-specific membrane antigen (PSMA) is one of the most specific cell surface markers for prostate cancer diagnosis and targeted treatment. However, achieving molecular imaging using non-invasive MRI with high resolution...
9.
Pu F, Xue S, Qiao J, Patel A, Yang J
Curr Protein Pept Sci
. 2016 Jan;
17(6):519-33.
PMID: 26721404
Prostate cancer is the most common cancer for man with a high mortality rate due to a lack of non-invasive accurate and sensitive molecular diagnostic methods. The molecular imaging of...
10.
GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
Pu F, Qiao J, Xue S, Yang H, Patel A, Wei L, et al.
Sci Rep
. 2015 Nov;
5:16214.
PMID: 26577829
Gastrin-releasing peptide receptor (GRPR) is differentially expressed on the surfaces of various diseased cells, including prostate and lung cancer. However, monitoring temporal and spatial expression of GRPR in vivo by...